Selected article for: "adaptive innate immunity and adjuvant treatment"
Author: Annweiler, Cédric; Cao, Zhijian; Sabatier, Jean-Marc
Title: Point of view: Should COVID-19 patients be supplemented with vitamin D?
  • Cord-id: 1ltlaro5
  • Document date: 2020_6_8
    • ID: 1ltlaro5
    Snippet: Using Hill's methodology for exploring causality, we aimed to determine in early May 2020 whether evidence supports vitamin D as a biological determinant of COVID-19 outcomes. Vitamin D is a secosteroid hormone theoretically able to reduce COVID-19 risk through regulation of (i) the renin-angiotensin system, (ii) cellular innate and adaptive immunity, and (iii) physical barriers. Inverse associations were found between 25-hydroxyvitamin D concentrations and COVID-19 incidence and mortality. Rand
    Document: Using Hill's methodology for exploring causality, we aimed to determine in early May 2020 whether evidence supports vitamin D as a biological determinant of COVID-19 outcomes. Vitamin D is a secosteroid hormone theoretically able to reduce COVID-19 risk through regulation of (i) the renin-angiotensin system, (ii) cellular innate and adaptive immunity, and (iii) physical barriers. Inverse associations were found between 25-hydroxyvitamin D concentrations and COVID-19 incidence and mortality. Randomized controlled trials testing vitamin D supplementation in the treatment of COVID-19 are in progress. Positive results in such studies would encourage the use of vitamin D supplements as an adjuvant treatment in COVID-19.

    Search related documents:
    Co phrase search for related documents
    • active form and adaptive immunity: 1, 2
    • acute ards respiratory disease syndrome and adaptive immunity: 1
    • acute ards respiratory disease syndrome and lung alveolar: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory disease syndrome and lung alveolar epithelial cell: 1, 2
    • acute ards respiratory disease syndrome and lung permeability: 1, 2
    • acute respiratory tract infection and adaptive immunity: 1
    • adaptive immunity and adjuvant treatment: 1, 2, 3, 4
    • adaptive immunity and lung alveolar: 1
    • adaptive immunity cellular innate and lung alveolar: 1